Patient Derived Xenograft Models Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

1 RESEARCH SCOPE

1.1 Research Product Definition

1.2 Research Segmentation

1.2.1 Product Type

1.2.2 Main product Type of Major Players

1.3 Demand Overview

1.4 Research Methodology

2 GLOBAL PATIENT DERIVED XENOGRAFT MODELS INDUSTRY

2.1 Summary about Patient Derived Xenograft Models Industry

2.2 Patient Derived Xenograft Models Market Trends

2.2.1 Patient Derived Xenograft Models Production & Consumption Trends

2.2.2 Patient Derived Xenograft Models Demand Structure Trends

2.3 Patient Derived Xenograft Models Cost & Price

3 MARKET DYNAMICS

3.1 Manufacturing & Purchasing Behavior in 2020

3.2 Market Development under the Impact of COVID-19

3.2.1 Drivers

3.2.2 Restraints

3.2.3 Opportunity

3.2.4 Risk

4 GLOBAL MARKET SEGMENTATION

4.1 Region Segmentation (2017 to 2021f)

4.1.1 North America (U.S., Canada and Mexico)

4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)

4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)

4.1.4 South America (Brazil,, Argentina, Rest of Latin America)

4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)

4.2 Product Type Segmentation (2017 to 2021f)

4.2.1 Mice Models 

4.2.2 Rat Models

4.3 Consumption Segmentation (2017 to 2021f)

4.3.1 Pharmaceutical & Biotechnology Companies 

4.3.2 Contract Research Organizations 

4.3.3 Academic & Research Institutions

5 NORTH AMERICA MARKET SEGMENT

5.1 Region Segmentation (2017 to 2021f)

5.1.1 U.S.

5.1.2 Canada

5.1.3 Mexico

5.2 Product Type Segmentation (2017 to 2021f)

5.2.1 Mice Models 

5.2.2 Rat Models

5.3 Consumption Segmentation (2017 to 2021f)

5.3.1 Pharmaceutical & Biotechnology Companies 

5.3.2 Contract Research Organizations 

5.3.3 Academic & Research Institutions

5.4 Impact of COVID-19 in North America

6 EUROPE MARKET SEGMENTATION

6.1 Region Segmentation (2017 to 2021f)

6.1.1 Germany

6.1.2 UK

6.1.3 France

6.1.4 Italy

6.1.5 Rest of Europe

6.2 Product Type Segmentation (2017 to 2021f)

6.2.1 Mice Models 

6.2.2 Rat Models

6.3 Consumption Segmentation (2017 to 2021f)

6.3.1 Pharmaceutical & Biotechnology Companies 

6.3.2 Contract Research Organizations 

6.3.3 Academic & Research Institutions

6.4 Impact of COVID-19 in Europe

7 ASIA-PACIFIC MARKET SEGMENTATION

7.1 Region Segmentation (2017 to 2021f)

7.1.1 China

7.1.2 India

7.1.3 Japan

7.1.4 South Korea

7.1.5 Southeast Asia

7.1.6 Australia

7.1.7 Rest of Asia Pacific

7.2 Product Type Segmentation (2017 to 2021f)

7.2.1 Mice Models 

7.2.2 Rat Models

7.3 Consumption Segmentation (2017 to 2021f)

7.3.1 Pharmaceutical & Biotechnology Companies 

7.3.2 Contract Research Organizations 

7.3.3 Academic & Research Institutions

7.4 Impact of COVID-19 in Europe

8 SOUTH AMERICA MARKET SEGMENTATION

8.1 Region Segmentation (2017 to 2021f)

8.1.1 Brazil

8.1.2 Argentina

8.1.3 Rest of Latin America

8.2 Product Type Segmentation (2017 to 2021f)

8.2.1 Mice Models 

8.2.2 Rat Models

8.3 Consumption Segmentation (2017 to 2021f)

8.3.1 Pharmaceutical & Biotechnology Companies 

8.3.2 Contract Research Organizations 

8.3.3 Academic & Research Institutions

8.4 Impact of COVID-19 in Europe

9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION

9.1 Region Segmentation (2017 to 2021f)

9.1.1 GCC

9.1.2 North Africa

9.1.3 South Africa

9.1.4 Rest of Middle East and Africa

9.2 Product Type Segmentation (2017 to 2021f)

9.2.1 Mice Models 

9.2.2 Rat Models

9.3 Consumption Segmentation (2017 to 2021f)

9.3.1 Pharmaceutical & Biotechnology Companies 

9.3.2 Contract Research Organizations 

9.3.3 Academic & Research Institutions

9.4 Impact of COVID-19 in Europe

10 COMPETITION OF MAJOR PLAYERS

10.1 Brief Introduction of Major Players

10.1.1 Crown Bioscience Inc. (US) 

10.1.2 WuXi AppTec (China) 

10.1.3 Champions Oncology, Inc. (US) 

10.1.4 The Jackson Laboratory (US) 

10.1.5 ONCODESIGN (France) 

10.1.6 Charles River Laboratories International, Inc. (US) 

10.1.7 EPO Berlin-Buch GmBH (Germany) 

10.1.8 Shanghai LIDE Biotech Co., Ltd (China) 

10.1.9 Xentech (France) 

10.1.10 Horizon Discovery Group PLC (UK) 

10.1.11 Urolead (France) 

10.1.12 Explora BioLabs (US)

10.2 Patient Derived Xenograft Models Sales Date of Major Players (2017-2020e)

10.2.1 Crown Bioscience Inc. (US) 

10.2.2 WuXi AppTec (China) 

10.2.3 Champions Oncology, Inc. (US) 

10.2.4 The Jackson Laboratory (US) 

10.2.5 ONCODESIGN (France) 

10.2.6 Charles River Laboratories International, Inc. (US) 

10.2.7 EPO Berlin-Buch GmBH (Germany) 

10.2.8 Shanghai LIDE Biotech Co., Ltd (China) 

10.2.9 Xentech (France) 

10.2.10 Horizon Discovery Group PLC (UK) 

10.2.11 Urolead (France) 

10.2.12 Explora BioLabs (US)

10.3 Market Distribution of Major Players

10.4 Global Competition Segmentation

11 MARKET FORECAST

11.1 Forecast by Region

11.2 Forecast by Demand

11.3 Environment Forecast

11.3.1 Impact of COVID-19

11.3.2 Geopolitics Overview

11.3.3 Economic Overview of Major Countries

12 REPORT SUMMARY STATEMENT

Table Patient Derived Xenograft Models Product Type Overview

Table Patient Derived Xenograft Models Product Type Market Share List

Table Patient Derived Xenograft Models Product Type of Major Players

Table Brief Introduction of Crown Bioscience Inc. (US) 

Table Brief Introduction of WuXi AppTec (China) 

Table Brief Introduction of Champions Oncology, Inc. (US) 

Table Brief Introduction of The Jackson Laboratory (US) 

Table Brief Introduction of ONCODESIGN (France) 

Table Brief Introduction of Charles River Laboratories International, Inc. (US) 

Table Brief Introduction of EPO Berlin-Buch GmBH (Germany) 

Table Brief Introduction of Shanghai LIDE Biotech Co., Ltd (China) 

Table Brief Introduction of Xentech (France) 

Table Brief Introduction of Horizon Discovery Group PLC (UK) 

Table Brief Introduction of Urolead (France) 

Table Brief Introduction of Explora BioLabs (US)

Table Products & Services of Crown Bioscience Inc. (US) 

Table Products & Services of WuXi AppTec (China) 

Table Products & Services of Champions Oncology, Inc. (US) 

Table Products & Services of The Jackson Laboratory (US) 

Table Products & Services of ONCODESIGN (France) 

Table Products & Services of Charles River Laboratories International, Inc. (US) 

Table Products & Services of EPO Berlin-Buch GmBH (Germany) 

Table Products & Services of Shanghai LIDE Biotech Co., Ltd (China) 

Table Products & Services of Xentech (France) 

Table Products & Services of Horizon Discovery Group PLC (UK) 

Table Products & Services of Urolead (France) 

Table Products & Services of Explora BioLabs (US)

Table Market Distribution of Major Players

Table Global Major Players Sales Revenue (Million USD) 2017-2020e

Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e

Table Global Patient Derived Xenograft Models Market Forecast (Million USD) by Region 2021f-2026f

Table Global Patient Derived Xenograft Models Market Forecast (Million USD) Share by Region 2021f-2026f

Table Global Patient Derived Xenograft Models Market Forecast (Million USD) by Demand 2021f-2026f

Table Global Patient Derived Xenograft Models Market Forecast (Million USD) Share by Demand 2021f-2026f